1800 202 8726
Prostate biopsy report

Does Gleason Score — Decide Your Treatment?

Your biopsy report carries a number that can feel like a verdict. It is an important number — but it is one part of a larger picture that your urologist reads together before recommending a plan.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • One input, not the whole answer — The score grades how aggressive the cancer cells appear. Your PSA, scan, biopsy volume and general health all matter too.
  • Grade Group simplifies the score — Your report may show both systems. They describe the same finding — Grade Group is usually easier to follow.
  • Volume changes the picture — The same grade across many cores looks different from the same grade in a small area of one core.
  • Your urologist reads the whole — No single number makes the decision. The plan comes from reading everything together.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The Gleason score is an important part of risk assessment, but it does not determine treatment on its own. Your PSA level, MRI findings, the amount of cancer in the biopsy, your age and your general health all combine. Your urologist or oncologist weighs all of these to recommend a treatment direction.

What do the terms on your biopsy report mean?

Gleason pattern
A number from 1 to 5 assigned to one area of cancer tissue based on how the cells appear under the microscope. Lower numbers look closer to normal prostate tissue; higher numbers look more disrupted.
Gleason score
The sum of the two most common patterns found in your sample. Because grading below 3 is rarely reported clinically, most scores fall between 6 and 10. Your report will show both numbers — for example, 3+4 — as well as the total.
Grade Group
A 1-to-5 scale that maps to the Gleason score and was introduced to make it easier to communicate. Grade Group 1 corresponds to the lowest-risk appearance; Grade Group 5 to the highest. Your report may show both systems.
PSA level
A protein measured in your blood before the biopsy. It is used alongside the grade — neither figure tells the full story without the other.
Clinical stage
What physical examination and imaging suggest about whether the cancer appears confined to the prostate or may have spread beyond it. Stage and grade together shape the treatment discussion.
Core positivity
The number of tissue cores taken that contained cancer, and how much of each core was involved. The same grade in one small core is a different situation from the same grade across most of the cores.

How much does the Gleason score actually decide?

The score tells your team how aggressive the cancer cells appear. That matters — but it is one dimension of a multidimensional picture.

PSA level adds a second dimension. An elevated PSA that does not match what the biopsy shows is a signal your team will investigate rather than ignore.

MRI findings add a third. Imaging shows whether the cancer appears contained within the prostate or may have reached the capsule or surrounding structures. The same grade looks different in each of those situations.

Your age and general health feed into the same conversation. A treatment approach that suits a 55-year-old does not automatically suit an 80-year-old, even with an identical biopsy report.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Who brings all of this together into a plan?

Your urologist or oncologist puts the picture together — the grade, the PSA, the imaging, how much of the biopsy was involved, and what you have told them about your priorities and your health.

For many prostate cancers, this review happens in a multidisciplinary team meeting, where a urologist, oncologist and radiologist look at the same evidence and reach a recommendation together.

No single number on your biopsy report makes that decision for them. The report gives your team the information. They give you the plan.

What to bring and ask at your next appointment

  • Bring your biopsy report and any recent PSA results
  • Ask your doctor to explain your Grade Group, not just the total score
  • Ask what the MRI showed, if one was done
  • Ask whether your case will be reviewed by a multidisciplinary team
  • Ask what the treatment options are and what each one is intended to achieve
  • Write down the answers — these conversations are hard to recall afterwards

Explore 114 more Waiting For and Understanding Your Report topics

HUB — Cytology and Prostate Scoring Systems Explained

HUB — Understanding Your Biopsy Report

HUB — Waiting for Biopsy Results

All Waiting For and Understanding Your Report →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does a Gleason score alone decide whether I need immediate treatment?

No. The score tells your team how aggressive the cancer cells appear, but it does not alone determine whether treatment is needed now. Your PSA, MRI findings, how much of the biopsy was involved, and your age and health all contribute. Some people with a given score are suitable for active surveillance; others are not. Your urologist will weigh all of those factors before making a recommendation.

What is the difference between Gleason 3+4 and 4+3?

Both add to the same total, but the two numbers describe the tissue differently. The first number represents the most prevalent pattern found in the biopsy and the second represents the next most common. Because the first number describes the dominant pattern, 3+4 and 4+3 describe different tissue pictures even though the totals match. Your urologist will explain what the specific combination in your biopsy means for your situation.

Can the Gleason score change after surgery?

Yes, and this is common. A biopsy samples only part of the prostate, while surgical removal allows the entire gland to be examined. The final grading is based on the complete specimen and is considered more accurate than the biopsy grade alone. If the score changes, your urologist will explain what that means for any further review or next steps.

Is active surveillance only for low-grade cancers?

Active surveillance is most commonly offered for lower-grade, lower-volume cancers, but grade is not the only factor. PSA level and its trajectory over time, the number of cores involved, MRI appearances, your age and general health all contribute to that decision. Whether active surveillance is appropriate for your specific situation is something your urologist and oncologist can answer from your complete results.

My PSA is high but my Gleason score is low — what does that mean?

It means the two findings are pointing in different directions, which is why your team reads neither in isolation. A high PSA alongside a lower grade can reflect the volume of cancer present, benign prostate enlargement, inflammation or other factors. Your urologist will look at both together with your scan results to understand what is driving the PSA before making any recommendation.

What questions should I ask at my appointment?

Ask your urologist to explain your Grade Group alongside the Gleason score — Grade Group is the cleaner number to follow. Ask what your PSA level and any MRI findings add to the picture. Ask whether your case will be reviewed by a multidisciplinary team and, if so, when. Ask what the treatment options are and what each one aims to achieve. Writing the answers down helps, because these conversations are difficult to recall under pressure.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation